<DOC>
	<DOC>NCT02314962</DOC>
	<brief_summary>Diagnostic comparison between PET/CT and PET/MRI with integrated perfusion measurement in CT and MR. Study aim is to gain knowledge about additional value of CT perfusion and MR perfusion in solid tumors concerning tumor physiology, diagnostic accuracy and possibly prognostic.</brief_summary>
	<brief_title>PET/MRI Perfusion and CT Perfusion in Solid Tumors</brief_title>
	<detailed_description />
	<criteria>indication as stated above written informed consent patients with suspected or confirmed solid malignant tumors of the neck, chest or abdomen who have an indication for a PET/CT pregnant or breast feeding women non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia) Inclusion in another clinical trial 30 days prior to inclusion age &lt; 30years contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia known allergies to contrast CT or MRI contrast media patients with an glomerular filtration rate of &lt; 60ml/min/1.73m2</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>